The Medication Level Variability Index (MLVI) as a potential predictive biomarker of graft‐versus‐host disease in pediatric hematopoietic stem cell transplant patients
2019 ◽
Vol 41
(3)
◽
pp. 268-271
◽
2014 ◽
Vol 22
(2)
◽
pp. 228-234
◽
2018 ◽
Vol 35
(1)
◽
pp. 83-88
◽
2017 ◽
Vol 23
(7)
◽
pp. 1122-1127
◽
2009 ◽
Vol 15
(11)
◽
pp. 1400-1406
◽
2018 ◽
Vol 24
(3)
◽
pp. S198
2008 ◽
Vol 14
(2)
◽
pp. 157-158